Endocrine Disruptor Chemicals and Children's Health
- PMID: 36768991
- PMCID: PMC9916521
- DOI: 10.3390/ijms24032671
Endocrine Disruptor Chemicals and Children's Health
Abstract
We are all exposed to endocrine-disrupting chemicals (EDCs) starting from embryonic life. The fetus and child set up crucial developmental processes allowing adaptation to the environment throughout life: they are extremely sensitive to very low doses of hormones and EDCs because they are developing organisms. Considering the developmental origin of well-being and diseases, every adult organism expresses consequences of the environment in which it developed. The molecular mechanisms through which the main EDCs manifest their effects and their potential association with endocrine disorders, such as diabetes, obesity, thyroid disease and alteration of adrenal hormones, will be reviewed here. Despite 40 years having passed since the first study on EDCs, little is yet known about them; therefore, our purpose is to take stock of the situation to establish a starting point for further studies. Since there is plenty of evidence showing that exposure to EDCs may adversely impact the health of adults and children through altered endocrine function-suggesting their link to endocrinopathies-it is essential in this context to bear in mind what is already known about endocrine disruptors and to deepen our knowledge to establish rules of conduct aimed at limiting exposure to EDCs' negative effects. Considering that during the COVID-19 pandemic an increase in endocrine disruptor effects has been reported, it will also be useful to address this new phenomenon for better understanding its basis and limiting its consequences.
Keywords: COVID-19; endocrine disruptors; endocrine-disrupting chemicals; endocrinopathies; pediatrics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Lamb J.C., Boffetta P., Foster W.G., Goodman J.E., Hentz K.L., Rhomberg L.R., Staveley J., Swaen G., Van Der Kraak G., Williams A.L. Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals—2012. Regul. Toxicol. Pharmacol. 2014;69:22–40. doi: 10.1016/j.yrtph.2014.02.002. - DOI - PubMed
-
- Zoeller R.T., Brown T.R., Doan L.L., Gore A.C., Skakkebaek N.E., Soto A.M., Woodruff T.J., Vom Saal F.S. Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. Endocrinology. 2012;153:4097–4110. doi: 10.1210/en.2012-1422. - DOI - PMC - PubMed
-
- Woodruff T.J., Zeise L., Axelrad D.A., Guyton K.Z., Janssen S., Miller M., Miller G.G., Schwartz J.M., Alexeeff G., Anderson H., et al. Meeting Report: Moving Upstream—Evaluating Adverse Upstream End Points for Improved Risk Assessment and Decision-Making. Environ. Health Perspect. 2008;116:1568–1575. doi: 10.1289/ehp.11516. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
